Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2526)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5696)
  2. Department of Medicine (5686)
  3. GSK Faculty (1659)
  4. Human Oncology and Pathogenesis Program (1158)
  5. Department of Pathology and Laboratory Medicine (1130)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (786)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (204)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (690)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5696)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Population-scale identification of clonal hematopoiesis derived mutations in solid tumor mutation profiling
    Meeting Abstract

    Ptashkin, R.; Coombs, C. C.; Hyman, D. M.; Solit, D.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; Levine, R. L.; Berger, M. F.; Zehir, A.
    Blood (2017)

    Fulltext@MSK | Save
  • Observational longitudinal study of pain in men with metastatic castrate-resistant prostate cancer: Aim 1. Rates of pain palliation and pain progression as indicated by self-reported daily pain and analgesic use
    Meeting Abstract

    Bennett, A. V.; Shouery, M.; Wang, M.; Whang, Y. E.; Milowsky, M.; Drier, S.; Carr, P.; Graff, J. N.; Morris, M. J.; Scher, H. I.; more...
    Quality of Life Research (2017)

    Fulltext@MSK | Save
  • Tumor xenografts of human clear cell renal cell carcinoma but not corresponding cell lines recapitulate clinical response to sunitinib: Feasibility of using biopsy samples
    Journal Article

    Dong, Y.; Manley, B. J.; Becerra, M. F.; Redzematovic, A.; Casuscelli, J.; Tennenbaum, D. M.; Reznik, E.; Han, S.; Benfante, N.; Chen, Y. B.; more...
    European Urology Focus (2017)

    Fulltext@MSK | Save
  • Effective prostate-specific membrane antigen-based (18)F-DCFPyL-guided cryoablation of a single positive site in a patient believed to be more metastatic on (11)C-choline PET/CT
    Journal Article

    Cornelis, F. H.; Durack, J. C.; Morris, M. J.; Scher, H. I.; Solomon, S. B.
    Clinical Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Keynote-045: Open-label, phase 3 study of pembrolizumab versus investigator's choice of paclitaxel, docetaxel, or vinflunine for previously treated advanced urothelial cancer
    Meeting Abstract

    Quinn, D.; Bellmunt, J.; de Wit, R.; Vaughn, D. J.; Fradet, Y.; Lee, J. L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; more...
    Asia-Pacific Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Health-related quality of life (HRQoL) of pembrolizumab vs chemotherapy for previously treated advanced urothelial cancer (UC) in KEYNOTE-045
    Meeting Abstract

    Quinn, D.; Vaughn, D. J.; Bellmunt, J.; de Wit, R.; Fradet, Y.; Lee, J. L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; more...
    Asia-Pacific Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Trial of rucaparib in prostate indications 2 (TRITON2): An international, multicentre, open-label phase 2 study of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)
    Meeting Abstract

    Shapiro, J.; Voskoboynik, M.; Krieger, L.; Byard, I.; Clay, T.; Ganju, V.; Abida, W.; Chowdhury, S.; Watkins, S.; Despain, D.; more...
    Asia-Pacific Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Does neoadjuvant androgen deprivation therapy impact erectile function recovery post-radical prostatectomy?
    Meeting Abstract

    Jenkins, L.; Touijer, K.; Rathkopf, D.; Nelson, C.; Mulhall, J.
    Journal of Sexual Medicine (2017)

    Fulltext@MSK | Save
  • Efficacy of PEGylated human IL-10 (AM0010) in combination with anti-PD-1 blockade in patients (pts) with metastatic renal cell carcinoma (mRCC): A phase 1b trial
    Meeting Abstract

    Naing, A.; Infante, J.; Wong, D.; Korn, W. M.; Aljumaily, R.; Papadopoulos, K.; Autio, K.; Pant, S.; Bauer, T.; Drakaki, A.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • PEGylated human IL-10 (AM0010) in combination with an anti-PD-1 in advanced NSCLC
    Meeting Abstract

    Wong, D.; Schneider, J. G.; Aljumaily, R.; Korn, W. M.; Infante, J.; Patel, M.; Autio, K.; Papadopoulos, K.; Naing, A.; Gabrail, N. Y.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save